Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners
Abstract Background The therapeutic decision toward patients with schizophrenia is very different from one psychiatrist to another when faced with potentially similar clinical symptoms. It depends on many factors that are related to the patient’s and the doctor’s profiles, and the drug’s characteris...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-05-01
|
Series: | Middle East Current Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43045-023-00313-5 |
_version_ | 1797823022204190720 |
---|---|
author | Khadija Benallel Wafaa Mansouri Jalal Salim Roukaya Benjelloun Mohamed Kadiri |
author_facet | Khadija Benallel Wafaa Mansouri Jalal Salim Roukaya Benjelloun Mohamed Kadiri |
author_sort | Khadija Benallel |
collection | DOAJ |
description | Abstract Background The therapeutic decision toward patients with schizophrenia is very different from one psychiatrist to another when faced with potentially similar clinical symptoms. It depends on many factors that are related to the patient’s and the doctor’s profiles, and the drug’s characteristics. To date, no study has been conducted in Morocco on the prescribing habits of psychiatrists toward patients with schizophrenia. The objectives of our survey are to identify the molecules most prescribed by psychiatrists in Morocco for patients with schizophrenia and to determine the most common therapeutic strategies. Results Our survey recruited 72 Moroccan psychiatrists. The median age was 36.5 years. 72.2% were women, and 37.5% had between 5 and 10 years of practice. More than two-thirds were practicing in the public sector in big cities. Olanzapine was an antipsychotic prescribed as first-line treatment for a patient with schizophrenia. For the majority, the most frequent combination was atypical antipsychotics with conventional neuroleptics. On the one hand, most psychiatrists reported prescribing neuroleptics long-acting injectable (neuroleptic LAIs). In the other hand, almost half of the participants had never prescribed second-generation antipsychotic long-acting injectables (SGA-LAIs). The high cost (77.8%), lack of availability of the product in certain sectors (33.3%), lack of therapeutic choice (26.4%), and lack of patient profile that could use the drug (23.6%), were among the strong reasons given for not prescribing SGA-LAIs. Conclusions The treatment decision for patients with schizophrenia differs from one clinician to the other. It depends on various factors that may be related to the psychiatrist, the patient, and to the drug. |
first_indexed | 2024-03-13T10:18:02Z |
format | Article |
id | doaj.art-86061dc8f79540bc88761d92abdc23c2 |
institution | Directory Open Access Journal |
issn | 2090-5416 |
language | English |
last_indexed | 2024-03-13T10:18:02Z |
publishDate | 2023-05-01 |
publisher | SpringerOpen |
record_format | Article |
series | Middle East Current Psychiatry |
spelling | doaj.art-86061dc8f79540bc88761d92abdc23c22023-05-21T11:06:57ZengSpringerOpenMiddle East Current Psychiatry2090-54162023-05-013011810.1186/s43045-023-00313-5Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitionersKhadija Benallel0Wafaa Mansouri1Jalal Salim2Roukaya Benjelloun3Mohamed Kadiri4Psychiatry Department, Mohammed V Military Hospital, Mohammed V University of RabatPsychiatry Department, Mohammed V Military Hospital, Mohammed V University of RabatPsychiatry Department, Mohammed V Military Hospital, Mohammed V University of RabatPsychiatry Department, Cheikh Khalifa International University Hospital, Mohammed VI University of Health SciencesPsychiatry Department, Mohammed V Military Hospital, Mohammed V University of RabatAbstract Background The therapeutic decision toward patients with schizophrenia is very different from one psychiatrist to another when faced with potentially similar clinical symptoms. It depends on many factors that are related to the patient’s and the doctor’s profiles, and the drug’s characteristics. To date, no study has been conducted in Morocco on the prescribing habits of psychiatrists toward patients with schizophrenia. The objectives of our survey are to identify the molecules most prescribed by psychiatrists in Morocco for patients with schizophrenia and to determine the most common therapeutic strategies. Results Our survey recruited 72 Moroccan psychiatrists. The median age was 36.5 years. 72.2% were women, and 37.5% had between 5 and 10 years of practice. More than two-thirds were practicing in the public sector in big cities. Olanzapine was an antipsychotic prescribed as first-line treatment for a patient with schizophrenia. For the majority, the most frequent combination was atypical antipsychotics with conventional neuroleptics. On the one hand, most psychiatrists reported prescribing neuroleptics long-acting injectable (neuroleptic LAIs). In the other hand, almost half of the participants had never prescribed second-generation antipsychotic long-acting injectables (SGA-LAIs). The high cost (77.8%), lack of availability of the product in certain sectors (33.3%), lack of therapeutic choice (26.4%), and lack of patient profile that could use the drug (23.6%), were among the strong reasons given for not prescribing SGA-LAIs. Conclusions The treatment decision for patients with schizophrenia differs from one clinician to the other. It depends on various factors that may be related to the psychiatrist, the patient, and to the drug.https://doi.org/10.1186/s43045-023-00313-5Prescribing habitsMoroccan psychiatristSchizophreniaLong-acting injectableSecond generation antipsychotic |
spellingShingle | Khadija Benallel Wafaa Mansouri Jalal Salim Roukaya Benjelloun Mohamed Kadiri Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners Middle East Current Psychiatry Prescribing habits Moroccan psychiatrist Schizophrenia Long-acting injectable Second generation antipsychotic |
title | Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners |
title_full | Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners |
title_fullStr | Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners |
title_full_unstemmed | Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners |
title_short | Prescribing habits of Moroccan psychiatrists toward patients with schizophrenia: about 72 practitioners |
title_sort | prescribing habits of moroccan psychiatrists toward patients with schizophrenia about 72 practitioners |
topic | Prescribing habits Moroccan psychiatrist Schizophrenia Long-acting injectable Second generation antipsychotic |
url | https://doi.org/10.1186/s43045-023-00313-5 |
work_keys_str_mv | AT khadijabenallel prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners AT wafaamansouri prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners AT jalalsalim prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners AT roukayabenjelloun prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners AT mohamedkadiri prescribinghabitsofmoroccanpsychiatriststowardpatientswithschizophreniaabout72practitioners |